Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
7 drugs for “Bladder Cancer”
Approved 1
- TremelimumabASTRAZENECA PLCMuscle Invasive Bladder Cancer
Phase 3 5
- Cretostimogene grenadenorepvecCG Oncology, Inc.Non Muscle Invasive Bladder Cancer; Bladder Cancer; High-grade Ta/ T1 Papillary Disease Bladder Cancer
- N-803ImmunityBio, Inc.Bladder Cancer
- TARA-002Protara Therapeutics, Inc.Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
- UGN-102UroGen Pharma Ltd.Bladder Cancer
- UGN-103UroGen Pharma Ltd.Bladder Cancer
Phase 2/3 1
- CTX-009Compass Therapeutics, Inc.Gall Bladder Cancer
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.